Cite

HARVARD Citation

    Ungar, B. et al. (2021). Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms. Journal of Crohn's and colitis. pp. 1707-1719. [Online]. 
  
Back to record